Related Experiment Video
Updated: May 4, 2026

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani1,2, Hiroshi Mohri1,2, Bruce Culbertson3,4
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
SARS-CoV-2 can readily develop resistance to nirmatrelvir, an oral antiviral for COVID-19. In vitro studies show multiple mutation pathways leading to resistance, highlighting the need for next-generation antiviral design.
Area of Science:
- Virology
- Antiviral Drug Resistance
- Molecular Biology
Background:
- Nirmatrelvir is an oral antiviral effective against SARS-CoV-2.
- Concerns exist regarding SARS-CoV-2 evolving resistance to nirmatrelvir, similar to other antivirals.
Purpose of the Study:
- To investigate the potential for SARS-CoV-2 to develop in vitro resistance to nirmatrelvir.
- To identify mutations and pathways associated with nirmatrelvir resistance.
Main Methods:
- In vitro passaging of SARS-CoV-2 in the presence of nirmatrelvir.
- Genomic sequencing to identify mutations in the 3CL protease.
- Construction and analysis of recombinant SARS-CoV-2 clones.
Main Results:
- Highly resistant SARS-CoV-2 variants emerged through multiple independent pathways.
- Mutations were observed at 23 different residues of the 3CL protease.
- Specific mutations like T21I, P252L, and T304I were common precursors, with E166V conferring significant resistance.
Conclusions:
- SARS-CoV-2 readily develops resistance to nirmatrelvir in vitro via diverse mutational routes.
- Understanding these resistance mechanisms is crucial for designing next-generation protease inhibitors.
Related Concept Videos
Retroviruses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Subviral Agents
Inhibitors of Viral Protein Synthesis

